河南太龙药业股份有限公司关于在子公司之间调剂担保额度及为子公司融资提供担保的进展公告

Core Viewpoint - The announcement details the provision of guarantees by Henan Tailong Pharmaceutical Co., Ltd. for its subsidiary, Beijing New Leading Pharmaceutical Technology Development Co., Ltd., to support its operational and financing needs through agreements with banks [1][2]. Group 1: Guarantee Details - The company signed a guarantee contract with Dalian Bank Beijing Branch for a principal amount of RMB 10 million, effective from February 2, 2026, to February 1, 2027 [1]. - A maximum guarantee contract was signed with Jiangsu Bank Beijing Branch for a principal amount of RMB 40 million, effective from January 29, 2026, to January 12, 2027 [1]. - The total guarantee amount provided by the company for its subsidiaries in 2025 is capped at RMB 43 million, with the ability to adjust the guarantee limits among subsidiaries [2]. Group 2: Internal Decision-Making Process - The board of directors approved the guarantee provision for subsidiaries during meetings held on April 7, 2025, and April 29, 2025, ensuring compliance with internal approval processes [2][9]. - The company has the authority to adjust unused guarantee limits among its subsidiaries, specifically reallocating RMB 21 million from Zhengzhou Deep Blue Sea Biomedical Technology Co., Ltd. to New Leading [2]. Group 3: Financial Stability and Risk Management - New Leading is not listed as a dishonest executor according to public records, indicating a stable financial status [3]. - The guarantees are deemed necessary to support the subsidiary's business development and financing needs, aligning with the company's strategic goals [7]. - The overall risk associated with the guarantees is considered manageable, as the company maintains effective control over New Leading's operations and decision-making [7][9]. Group 4: Cumulative Guarantee Situation - As of the announcement date, the total external guarantees provided by the company and its subsidiaries amount to RMB 344.67 million, representing 21.89% of the company's latest audited net assets [9]. - All guarantees are exclusively for wholly-owned and controlled subsidiaries, with no guarantees provided to controlling shareholders or related parties, and no overdue guarantees reported [9].